Gracell Biotechnologies I...

NASDAQ: GRCL · Real-Time Price · USD
10.25
0.01 (0.05%)
At close: Feb 21, 2024, 10:00 PM

Gracell Biotechnologies Income Statement

Financials in CNY. Fiscal year is January - December.
Fiscal Year FY 2022 FY 2021
Period Ending Dec 31, 2022 Dec 31, 2021
Revenue
n/a 366K
Cost of Revenue
n/a n/a
Gross Profit
n/a 366K
Operating Income
-624.66M -463.57M
Interest Income
23.92M 9.12M
Pretax Income
-607.49M -451.75M
Net Income
-607.51M -465.88M
Selling & General & Admin
139.27M 137.04M
Research & Development
485.39M 326.9M
Other Expenses
n/a n/a
Operating Expenses
624.66M 463.94M
Interest Expense
6.74M 5.06M
Selling & Marketing Expenses
n/a n/a
Cost & Expenses
624.66M 463.94M
Income Tax Expense
22K 14.13M
Shares Outstanding (Basic)
13.54M 13.15M
Shares Outstanding (Diluted)
13.54M 13.15M
EPS (Basic)
-44.85 -35.4
EPS (Diluted)
-44.85 -35.4
EBITDA
-592.58M -385.13M
EBIT
-600.75M -446.69M
Depreciation & Amortization
32.08M 78.45M